The CMHC Education Resource Center offers a single access point for educational resources and online courses featuring the expert content and faculty from CMHC live events. Stay current on the latest clinical research and strategies, while testing your knowledge of essential topics in cardiometabolic risk management and CVD prevention. Select from a comprehensive array of complimentary CME-CE activities in a variety of formats to meet your needs, available on-demand and on-the-go!
This clinical brief, adapted from a presentation at the 2021 CMHC Spring meeting, offers an overview of insulin pumps and insulin delivery systems for T2DM, as well as expert feedback and practical strategies on how to integrate them to patient care.
Several cardiometabolic comorbidities, including overweight/obesity, dyslipidemia, cardiovascular diseases, hypertension, and type 2 diabetes or insulin resistance, are common in patients with narcolepsy. Often these disorders are overlooked, but they have important implications in the management of these patients. Some medications used to treat symptoms of narcolepsy may have potential negative effects on cardiovascular health and long-term data on the cardiovascular safety of narcolepsy treatments are generally lacking. Given these gaps, clinicians would benefit from additional education on how to screen, identify, and better tailor the management of narcolepsy in these patients.